-
| Sector | |
|---|---|
| Industry | |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | KYG1125A1085 |
| Beta | nan |
|---|---|
| Market Cap | 292M |
| PE Ratio | 39.04 |
| Target Price | None |
| Dividend Yield | 0.0% |
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BIOT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025